Clinical Trial Update: Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease [Phase 1]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1 relative bioavailability study evaluating four experimental formulations for Alzheimer's disease, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer's Disease, Healthy | Phase 1 | Status: COMPLETED